The most compelling direct evidence comes from a recent study by Zhang et al., which demonstrated that the administration of glial growth factor 2 (GGF2) alleviated cerebral ischemia–reperfusion injury by specifically upregulating Mfsd2a. The gene discussed is NRG1; the disease is brain ischemia.